Plus d'informations
Scientists from the International Agency for Research on Cancer (IARC), in collaboration with researchers from the University of South Carolina, the Danish Cancer Institute, City of Hope, Memorial Sloan Kettering Cancer Center, the Mayo Clinic, and intramural investigators at the United States National Cancer Institute (NCI), have recently been awarded an important research grant by NCI to facilitate the collaborative research activities of the International Lymphoma Epidemiology Consortium (InterLymph). The consortium brings together lymphoma studies and data sets from around the world in order to better understand etiological risk factors related to lymphomas, as well as multiple myeloma.
IARC will take over as the InterLymph data coordinating centre (DCC), a key component of the consortium. The DCC acts as a repository to assemble and harmonize data from the various contributing studies. Through IARC’s expanded efforts and the support from this new research grant, the DCC will soon host data on genetic and environmental risk factors, as well as an array of genomic annotations, on about 48 000 lymphoma cases and more than 85 000 controls. Once the data have been harmonized, the DCC will make the data available to researchers with relevant research questions related to InterLymph’s research.
The Cervical Cancer Elimination Day of Action on 17 November 2024 marks the fourth year of a glob...
Scientists from the International Agency for Research on Cancer (IARC) and partner institutions h...
In a new paper, researchers from the International Agency for Research on Cancer (IARC) show that...